Citatuzumab (Anti-EpCAM / TROP1 / CD326)Citatuzumab (Anti-EpCAM / TROP1 / CD326)
Move your mouse over image or click to enlarge

Citatuzumab (Anti-EpCAM / TROP1 / CD326)

Citatuzumab (Anti-EpCAM / TROP1 / CD326) is a recombinant immunotoxin that composed of humanized monoclonal antibody targeting EpCAM. It has antitumor activity and can be used in treatment of cancer. MW :145.4 KD.
Cat# Size Price Qty Buy
A2651-1mg*25 1mg*25
£4,152.00
A2651-1mg*5 1mg*5
£1,384.00
A2651-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2651

Related Documents